Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLVT Clarivate	$4.32 -3.1%	$4.30	$3.04 ▼ $7.15	$3.05B	1.47	5.39 million shs	3.24 million shs
HQY HealthEquity	$94.52 -2.7%	$100.98	$65.01 ▼ $116.65	$8.40B	0.49	868,231 shs	1.11 million shs
MEDP Medpace	$323.50 -1.4%	$305.25	$250.05 ▼ $459.77	$9.43B	1.47	377,752 shs	293,644 shs
WPP WPP	$28.01 -4.4%	$37.60	$27.99 ▼ $57.37	$6.32B	1	251,091 shs	975,540 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLVT Clarivate	-1.00%	+2.06%	+0.68%	+35.92%	-18.82%
HQY HealthEquity	-2.79%	-2.37%	-9.35%	+18.24%	+22.96%
MEDP Medpace	+2.27%	+2.10%	+7.31%	+10.25%	-21.67%
WPP WPP	-0.39%	-19.41%	-21.63%	-16.92%	-37.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLVT Clarivate	2.1397 of 5 stars	1.8	1.0	0.0	0.0	2.1	4.2	1.9
HQY HealthEquity	3.7368 of 5 stars	3.5	3.0	0.0	0.0	2.7	2.5	1.9
MEDP Medpace	4.5392 of 5 stars	2.1	2.0	0.0	4.6	2.7	4.2	2.5
WPP WPP	2.3786 of 5 stars	0.0	3.0	2.5	0.0	2.8	0.0	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLVT Clarivate	1.67	Reduce	$5.00	15.74% Upside
HQY HealthEquity	3.00	Buy	$118.55	25.42% Upside
MEDP Medpace	2.21	Hold	$344.82	6.59% Upside
WPP WPP	2.60	Moderate Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest CLVT, MEDP, WPP, and HQY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/10/2025	WPP WPP	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underweight ➝ Underweight
7/10/2025	WPP WPP	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/8/2025	HQY HealthEquity	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$115.00 ➝ $120.00
6/25/2025	WPP WPP	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight
6/24/2025	MEDP Medpace	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform ➝ Equal Weight	$300.00
6/5/2025	HQY HealthEquity	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $125.00
6/5/2025	HQY HealthEquity	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$98.00 ➝ $115.00
6/4/2025	HQY HealthEquity	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$94.00 ➝ $104.00
6/4/2025	HQY HealthEquity	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $117.00
6/4/2025	HQY HealthEquity	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$110.00 ➝ $117.00
6/4/2025	HQY HealthEquity	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$110.00 ➝ $125.00

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLVT Clarivate	$2.56B	1.15	$1.62 per share	2.66	$7.23 per share	0.60
HQY HealthEquity	$1.20B	6.81	$4.15 per share	22.80	$24.40 per share	3.87
MEDP Medpace	$2.11B	4.41	$13.75 per share	23.53	$26.56 per share	12.18
WPP WPP	$18.84B	0.32	$8.29 per share	3.38	$22.12 per share	1.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLVT Clarivate	-$636.70M	-$0.97	6.86	6.35	N/A	-26.32%	8.75%	3.96%	8/5/2025 (Estimated)
HQY HealthEquity	$96.70M	$1.37	68.99	33.28	1.50	9.80%	11.01%	6.77%	9/2/2025 (Estimated)
MEDP Medpace	$404.39M	$13.10	24.69	23.68	5.94	19.31%	54.36%	20.81%	7/21/2025 (Confirmed)
WPP WPP	$692.62M	$5.97	4.69	5.15	N/A	N/A	N/A	N/A	8/5/2025 (Estimated)

Latest CLVT, MEDP, WPP, and HQY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	CLVT Clarivate	$0.18	N/A	N/A	N/A	$587.17 million	N/A
7/21/2025	Q2 2025	MEDP Medpace	$3.01	N/A	N/A	N/A	$537.70 million	N/A
6/3/2025	Q1 2026	HQY HealthEquity	$0.81	$0.97	+$0.16	$0.61	$322.25 million	$330.80 million
4/29/2025	Q1 2025	CLVT Clarivate	$0.12	$0.14	+$0.02	-$0.15	$574.03 million	$593.70 million
4/21/2025	Q1 2025	MEDP Medpace	$3.06	$3.67	+$0.61	$3.67	$528.38 million	$558.57 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLVT Clarivate	N/A	N/A	N/A	N/A	N/A
HQY HealthEquity	N/A	N/A	N/A	N/A	N/A
MEDP Medpace	N/A	N/A	N/A	N/A	N/A
WPP WPP	$0.49	1.75%	N/A	8.21%	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLVT Clarivate	0.90	0.88	0.88
HQY HealthEquity	0.50	4.06	4.06
MEDP Medpace	N/A	0.73	0.73
WPP WPP	1.00	0.88	0.88

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLVT Clarivate	85.72%
HQY HealthEquity	99.55%
MEDP Medpace	77.98%
WPP WPP	4.34%

Insider Ownership

Company	Insider Ownership
CLVT Clarivate	23.18%
HQY HealthEquity	1.50%
MEDP Medpace	20.30%
WPP WPP	1.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLVT Clarivate	12,000	683.09 million	524.75 million	Optionable
HQY HealthEquity	3,120	86.47 million	85.18 million	Optionable
MEDP Medpace	5,900	28.74 million	22.91 million	Optionable
WPP WPP	108,044	215.76 million	213.60 million	Optionable

CLVT, MEDP, WPP, and HQY Headlines

Recent News About These Companies

Wpp Plc (NYSE:WPP) Given Average Rating of "Moderate Buy" by Brokerages

July 10 at 3:08 PM | marketbeat.com

Advertising giant WPP taps new CEO to lead the firm in a challenging AI landscape

July 10 at 12:04 PM | fastcompany.comF

WPP's new CEO impresses but tough turnaround ahead, say analysts

July 10 at 11:48 AM | proactiveinvestors.co.uk

WPP names Microsoft leader Cindy Rose as next CEO

July 10 at 11:01 AM | adage.comA

WPP names Microsoft vet CEO in sign of AI’s rising role in advertising

July 10 at 11:01 AM | marketingdive.comM

WPP Names New CEO as Ad Giant Looks to AI Growth

July 10 at 10:15 AM | investopedia.com

Who is WPP's new CEO Cindy Rose?

July 10 at 6:10 AM | reuters.com

Cindy Rose to lead WPP into its AI-powered future, as holding group seeks reset

July 10 at 6:00 AM | marketing-interactive.comM

Microsoft exec named WPP boss as AI boom erodes advertising profits

July 10 at 6:00 AM | thisismoney.co.ukT

WPP hires Microsoft executive Cindy Rose as new boss

July 10 at 6:00 AM | msn.com

WPP appoints ex Microsoft, Vodafone divisional chief as new CEO

July 10 at 2:42 AM | proactiveinvestors.co.uk

WPP names Microsoft exec Cindy Rose as new CEO

July 10 at 2:10 AM | reuters.com

Advertising Giant WPP's Shares Plunge 18% As Economic Uncertainty, AI Threat Dim Forecasts

July 9 at 6:12 PM | deadline.comD

WPP Shares Plummet as Artificial Intelligence Undercuts Advertising

July 9 at 3:35 PM | barrons.com

Top Stock Movers Now: Nvidia, AES, WPP, and More

July 9 at 12:30 PM | investopedia.com

WPP (NYSE:WPP) Shares Gap Down - Should You Sell?

July 9 at 12:16 PM | marketbeat.com

WPP Stock Sinks 16%. Clients Are Spending Less on Advertising.

July 9 at 10:42 AM | barrons.com

WPP's dire profit warning is the last thing the ad business needs as it grapples with the impact of AI

July 9 at 10:24 AM | businessinsider.com

Ad giant WPP issues second profit warning this year. The stock is plunging.

July 9 at 4:02 AM | marketwatch.com

WPP slashes profit outlook as trading weakens

July 9 at 3:58 AM | sharecast.comS

WPP Cuts Guidance on Weaker Client Spending and New Business

July 9 at 3:58 AM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLVT, MEDP, WPP, and HQY Company Descriptions

Clarivate NYSE:CLVT

$4.32 -0.14 (-3.14%)

Closing price 03:59 PM Eastern

Extended Trading

$4.36 +0.04 (+0.83%)

As of 06:00 PM Eastern

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

HealthEquity NASDAQ:HQY

$94.52 -2.67 (-2.75%)

Closing price 04:00 PM Eastern

Extended Trading

$93.64 -0.88 (-0.94%)

As of 04:39 PM Eastern

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Medpace NASDAQ:MEDP

$323.50 -4.74 (-1.44%)

Closing price 04:00 PM Eastern

Extended Trading

$323.69 +0.19 (+0.06%)

As of 04:11 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

WPP NYSE:WPP

$28.01 -1.30 (-4.44%)

Closing price 03:59 PM Eastern

Extended Trading

$28.12 +0.11 (+0.41%)

As of 07:56 PM Eastern

WPP plc, a creative transformation company, provides communications, experience, commerce, and technology services in North America, the United Kingdom, Western Continental Europe, the Asia Pacific, Latin America, Africa, the Middle East, and Central and Eastern Europe. The company operates through three segments: Global Integrated Agencies, Public Relations, and Specialist Agencies. It offers marketing strategy, creative ideation, production, commerce, influencer marketing, social media management, and technology implementation services; media strategy, planning, buying and activation, commerce media, data analytics, and consulting services; and media management, public affairs, reputation, risk and crisis management, social media management, and strategic advisory services. The company also provides brand consulting, brand identity, product and service design, and corporate and brand publication services. WPP plc was founded in 1985 and is based in London, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time